Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Asensi V, Crespo M, Domingo P, Iribarren JA, Lázaro P, López-Aldeguer J, Lozano F, Martínez E, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, Santos J, de la Torre J, Tuset M, Gatell JM. Rivero A, et al. Among authors: domingo p. Enferm Infecc Microbiol Clin (Engl Ed). 2018 May;36(5):268-276. doi: 10.1016/j.eimc.2017.04.002. Epub 2017 May 19. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 28532596 English, Spanish.
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Podzamczer D, Miró JM, Bolao F, Gatell JM, Cosín J, Sirera G, Domingo P, Laguna F, Santamaría J, Verdejo J. Podzamczer D, et al. Among authors: domingo p. Ann Intern Med. 1995 Aug 1;123(3):175-80. doi: 10.7326/0003-4819-123-3-199508010-00003. Ann Intern Med. 1995. PMID: 7598298 Clinical Trial.
Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).
Suárez-Lozano I, Fajardo JM, Garrido M, Roca B, García-Alcalde ML, Geijo P, Selma D, Lozano F, Teira R, Viciana P, Pérez-Cortés S, Domingo P, Menchero A, Galindo MJ, Cosín J, Ribera E, Arribas JR, Lacalle JR. Suárez-Lozano I, et al. Among authors: domingo p. AIDS. 2002 Dec 6;16(18):2496-9. doi: 10.1097/01.aids.0000042931.55529.82. AIDS. 2002. PMID: 12461432 No abstract available.
[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)].
Teira R, Suárez-Lozano I, Muñoz P, Viciana P, Lozano F, Galindo MJ, Terrón A, Vergara A, Geijo P, Arribas JR, Cosín J, Domingo P, Ribera E, Roca B, García-Alcalde ML, Sánchez T, Muñoz-Sanz A. Teira R, et al. Among authors: domingo p. Enferm Infecc Microbiol Clin. 2005 Apr;23(4):213-7. doi: 10.1157/13073147. Enferm Infecc Microbiol Clin. 2005. PMID: 15826546 Spanish.
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.
Ochoa de Echagüen A, Arnedo M, Xercavins M, Martinez E, Rosón B, Ribera E, Domingo P, González A, Riera M, Llibre JM, Gatell JM, Dalmau D; Nevirapine, Efavirenz and Abacavir (NEFA) Resistance Substudy Team. Ochoa de Echagüen A, et al. Among authors: domingo p. AIDS. 2005 Sep 2;19(13):1385-91. doi: 10.1097/01.aids.0000181010.85255.3c. AIDS. 2005. PMID: 16103769 Clinical Trial.
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
Ribera E, Azuaje C, Lopez RM, Domingo P, Soriano A, Pou L, Sánchez P, Mallolas J, Sambea MA, Falco V, Ocaña I, Lopez-Colomes JL, Gatell JM, Pahissa A. Ribera E, et al. Among authors: domingo p. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):317-23. doi: 10.1097/01.qai.0000182629.74336.4d. J Acquir Immune Defic Syndr. 2005. PMID: 16249706 Clinical Trial.
767 results